{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470601949
| IUPAC_name = 2-<nowiki/>{[2-(thiophen-2-ylmethyl)phenoxy]methyl}morpholine
| image = Teniloxazine.svg
| width = 215
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 62473-79-4
| CAS_supplemental = <br />62473-80-7 ([[maleate]])
| ATC_prefix = None
| ATC_suffix = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 95Q6WNP25P
| PubChem = 119114
| ChemSpiderID = 106426
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| C = 16 | H = 19 | N = 1 | O = 2 | S = 1
| molecular_weight = 289.393 g/mol
| smiles = O1CCNCC1COc2ccccc2Cc3sccc3
| synonyms = Y-8894
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H19NO2S/c1-2-6-16(19-12-14-11-17-7-8-18-14)13(4-1)10-15-5-3-9-20-15/h1-6,9,14,17H,7-8,10-12H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OILWWIVKIDXCIB-UHFFFAOYSA-N
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
| pregnancy_category = 
| legal_status = Rx-only
| routes_of_administration = Oral
}}

'''Teniloxazine''' ('''Lucelan''', '''Metatone'''), also known as '''sufoxazine''' and '''sulfoxazine''', is a [[drug]] which is marketed in [[Japan]].<ref name="GanellinTriggle1997">{{cite book | author1 = C. R Ganellin | author2 = D. J Triggle | author3 = F.. Macdonald | title = Dictionary of pharmacological agents | url = https://books.google.com/books?id=A0THacd46ZsC&pg=PA1905 | accessdate=27 October 2011 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | pages = 1905}}</ref> Though initially investigated as a [[neuroprotection|neuroprotective]] and [[nootropic]] agent for the treatment of [[cerebrovascular insufficiency]] in the 1980s,<ref name="pmid2859238">{{cite journal |vauthors=Anami K, Yamamoto Y, Setoguchi M | title = [Pharmacological studies on sufoxazine (Y-8894). (I) Effects on experimental amnesia in mice] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 85 | issue = 2 | pages = 71–7 |date=February 1985 | pmid = 2859238 | doi = 10.1254/fpj.85.71| url = }}</ref><ref name="pmid4085932">{{cite journal |vauthors=Izumi N, Yasuda H | title = [Pharmacological studies on sufoxazine (Y-8894). (II). Anti-anoxic effect] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 86 | issue = 4 | pages = 323–8 |date=October 1985 | pmid = 4085932 | doi = 10.1254/fpj.86.323| url = }}</ref><ref name="pmid3491778">{{cite journal |vauthors=Usa T, Morimoto Y, Fukuda T, Anami K, Setoguchi M, Maruyama Y | title = [Pharmacological studies on Y-8894. (III). Its effect on the abnormal electrocorticogram induced by destruction of the internal capsule] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 88 | issue = 4 | pages = 289–97 |date=October 1986 | pmid = 3491778 | doi = 10.1254/fpj.88.289| url = }}</ref><ref name="pmid3817653">{{cite journal |vauthors=Yasuda H, Izumi N, Nakanishi M, Anami K, Maruyama Y | title = [Pharmacological studies on Y-8894. (IV). Ameliorative effect on a cerebral energy metabolism disorder induced by KCN] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 88 | issue = 5 | pages = 363–7 |date=November 1986 | pmid = 3817653 | doi = 10.1254/fpj.88.363| url = }}</ref><ref name="pmid2884174">{{cite journal |vauthors=Anami K, Yamamoto Y, Setoguchi M, Maruyama Y | title = [Pharmacological studies on Y-8894. (V) Effect on learning and memory in intact and experimentally amnesic rats] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 89 | issue = 3 | pages = 145–53 |date=March 1987 | pmid = 2884174 | doi = 10.1254/fpj.89.145| url = }}</ref><ref name="pmid2443434">{{cite journal |vauthors=Setoguchi M, Takehara S, Sakamori M, Anami K, Maruyama Y | title = [Pharmacological studies on Y-8894 (VI). The effect on monoamine uptake and turnover in mouse brain] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 90 | issue = 1 | pages = 41–9 |date=July 1987 | pmid = 2443434 | doi = 10.1254/fpj.90.41| url = }}</ref><ref name="pmid3443414">{{cite journal  |vauthors=Yasumatsu H, Yamamoto Y, Takamuku H, etal | title = [Pharmacological studies on Y-8894. (VII). Effects on transient cerebral ischemia-induced amnesia in rats] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 90 | issue = 6 | pages = 321–30 |date=December 1987 | pmid = 3443414 | doi = 10.1254/fpj.90.321| url = }}</ref><ref name="pmid3224898">{{cite journal |vauthors=Anami K, Setoguchi M, Senoh H | title = [Pharmacological studies on Y-8894. (VIII). Effects on learning and memory in the radial maze task in mice] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 92 | issue = 2 | pages = 113–8 |date=August 1988 | pmid = 3224898 | doi = 10.1254/fpj.92.113| url = }}</ref> it was ultimately developed and approved as an [[antidepressant]] instead.<ref name="pmid3593624">{{cite journal  |vauthors=Ogura C, Kishimoto A, Kunimoto N, etal | title = Clinical pharmacology of a new antidepressant, Y-8894 in healthy young and elderly volunteers | journal = British Journal of Clinical Pharmacology | volume = 23 | issue = 5 | pages = 537–43 |date=May 1987 | pmid = 3593624 | pmc = 1386189 | doi = 10.1111/j.1365-2125.1987.tb03089.x| url = }}</ref> It acts as a [[potency (pharmacology)|potent]] [[norepinephrine reuptake inhibitor]], with fair [[binding selectivity|selectivity]] over the [[serotonin]] and [[dopamine]] [[neurotransmitter transporter|transporter]]s, and also behaves as an [[receptor antagonist|antagonist]] of the [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]].<ref name="pmid2443434"/><ref name="pmid3593624"/><ref name="Kuriyama2009">{{cite web | url = http://www.google.com/patents?id=UNCzAAAAEBAJ&printsec=abstract#v=onepage | title = Therapeutic Agent for Attention-Deficit Hyperactivity Disorder - Google Patents | accessdate = October 27, 2011}}</ref>

== See also ==
* [[Bifemelane]]
* [[Indeloxazine]]
* [[Viloxazine]]

== References ==
{{Reflist|2}}

{{Antidepressants}}
{{Antidementia}}
{{Nootropics}}
{{Monoamine reuptake inhibitors}}
{{Serotonin receptor modulators}}

[[Category:Antidepressants]]
[[Category:Morpholines]]
[[Category:Thiophenes]]
[[Category:Phenol ethers]]